Compare Agilent Technologies Inc (A) vs Ulta Beauty Inc (ULTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Ulta Beauty Inc — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Ulta Beauty Inc trades at $542.13 (market cap $23.59B). The key difference: Agilent Technologies Inc is the larger of the two by market cap, and Agilent Technologies Inc pays a 0.69% dividend while Ulta Beauty Inc pays none. Which is the better fit depends on your goals.
| A | ULTA | |
|---|---|---|
Market Cap | $42.00B | $23.59B |
Sector | Health | Consumer Cyclical |
52-Week High | $157.20 | $706.82 |
52-Week Low | $110.24 | $450.75 |
Enterprise Value | $43.55B | $25.67B |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
ULTA stock trades at $565.15, up 4.89% in the last session, with a bullish technical outlook supported by moving averages and strong support at $547. The company reported Q1 2026 EPS of $7.74, beating estimates, but faces margin compression with net income margin declining to 10.63% in 2025. Recent news highlights the end of its Target partnership as a potential growth opportunity, per BofA analysis on July 29, 2026.
The stock offers upside to the consensus price target of $618.29, with 57% of analysts rating it a buy, but risks include competitive pressures and volatile cash flows, with net cash flow turning negative in 2025. Investors should weigh robust ROE of 47.45% against elevated P/B of 9.41 and RSI levels suggesting overbought conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Ulta Beauty Inc
With more than 1,300 stores and a partnership with Target, Ulta Beauty is the largest specialized beauty retailer in the U.S. The firm offers makeup (43% of 2021 sales), fragrances, skin care, and hair care products (20% of 2021 sales), and bath and body items. Ulta offers private-label products and merchandise from more than 500 vendors. It also offers salon services, including hair, makeup, skin, and brow services, in all stores. Most Ulta stores are approximately 10,000 square feet and are in suburban strip centers. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.
Read more on ULTA →
